Laura Soucek (@laurasoucek) 's Twitter Profile
Laura Soucek

@laurasoucek

Cancer will be defeated one day and I want to be there to see that happening

ID: 2527195206

calendar_today27-05-2014 11:01:44

921 Tweet

2,2K Followers

345 Following

Laura Soucek (@laurasoucek) 's Twitter Profile Photo

We are delighted to share that our review “MYC in cancer: from undruggable target to clinical trials” is finally out in Nature Reviews Drug Discovery. What an amazing journey this has been and still promises to be! Big thanks to co-author Jonathan Whitfield. rdcu.be/eawOK

Vall d’Hebron Institute of Oncology (VHIO) (@vhio) 's Twitter Profile Photo

#MYC: from undruggable target to the first cancer clinical trials 🔬 🗞️ Recently published as a Review Article in Nature Reviews Drug Discovery, Laura Soucek and Jonathan Whitfield provide an expert overview of the different strategies to inhibit MYC. ➡️ linke.to/MYNRDD_VHIO

#MYC: from undruggable target to the first cancer clinical trials 🔬

🗞️ Recently published as a Review Article in <a href="/NatRevDrugDisc/">Nature Reviews Drug Discovery</a>, <a href="/LauraSoucek/">Laura Soucek</a> and <a href="/jonywhitfield/">Jonathan Whitfield</a> provide an expert overview of the different strategies to inhibit MYC. ➡️ linke.to/MYNRDD_VHIO
Vall d’Hebron Institute of Oncology (VHIO) (@vhio) 's Twitter Profile Photo

#MYC: de diana terapéutica intratable a los primeros ensayos clínicos en pacientes con cáncer 🔬 🗞️ Recientemente publicado como artículo de revisión en Nature Reviews Drug Discovery, Laura Soucek y Jonathan Whitfield ofrecen una visión experta sobre las diferentes estrategias para inhibir MYC ➡️

#MYC: de diana terapéutica intratable a los primeros ensayos clínicos en pacientes con cáncer 🔬

🗞️ Recientemente publicado como artículo de revisión en <a href="/NatRevDrugDisc/">Nature Reviews Drug Discovery</a>, <a href="/LauraSoucek/">Laura Soucek</a> y <a href="/jonywhitfield/">Jonathan Whitfield</a> ofrecen una visión experta sobre las diferentes estrategias para inhibir MYC ➡️
Vall d’Hebron Institute of Oncology (VHIO) (@vhio) 's Twitter Profile Photo

#MYC: de diana terapèutica intractable als primers assaigs clínics en pacients amb càncer 🔬 Laura Soucek i Jonathan Whitfield han coliderat un article publicat a Nature Reviews Drug Discovery que analitza els esforços de la comunitat científica per desenvolupar aquest fàrmac. ➡️

#MYC: de diana terapèutica intractable als primers assaigs clínics en pacients amb càncer 🔬

<a href="/LauraSoucek/">Laura Soucek</a> i <a href="/jonywhitfield/">Jonathan Whitfield</a> han coliderat un article publicat a <a href="/NatRevDrugDisc/">Nature Reviews Drug Discovery</a> que analitza els esforços de la comunitat científica per desenvolupar aquest fàrmac. ➡️
Vall d’Hebron Institute of Oncology (VHIO) (@vhio) 's Twitter Profile Photo

#ESMOTAT25 📣 The corporate and investor mindset: What types of anticancer drugs and clinical research proposals will be prioritized in the near term? 💬 Laura Soucek, Cristian Massacesi, Shaily Arora, Yael Gruenbaum Cohen & Giovanni Abbadessa. 👉 esmo.org/meeting-calend…

#ESMOTAT25

📣 The corporate and investor mindset: What types of anticancer drugs and clinical research proposals will be prioritized in the near term?
đź’¬ <a href="/LauraSoucek/">Laura Soucek</a>, Cristian Massacesi, Shaily Arora, <a href="/GruenbaumYael/">Yael Gruenbaum Cohen</a> &amp; Giovanni Abbadessa.

👉 esmo.org/meeting-calend…
Laura Soucek (@laurasoucek) 's Twitter Profile Photo

I am proud to announce that the first patient was dosed in a Phase 2 clinical trial of OMO-103 in advanced osteosarcoma. I am extremely grateful to Vall d’Hebron Institute of Oncology (VHIO) and The Osteosarcoma Institute for making this possible. THANK YOU. This is a huge milestone. PEPTOMYC #OMO103 rb.gy/9hhaqa

Vall d’Hebron Institute of Oncology (VHIO) (@vhio) 's Twitter Profile Photo

¿Sabías que el plasma es clave para muchos tratamientos médicos❓ En VHIO nos sumamos al #RepteDor Banc de Sang para aumentar las donaciones de plasma en Cataluña 👇 #ViuiFesViure

Vall d’Hebron Institute of Oncology (VHIO) (@vhio) 's Twitter Profile Photo

#AACR25 | Laura Soucek, Director of VHIO’s Preclinical and Translational Research Program, has chaired and spoken at the AACR Annual Meeting on strategies to target MYC, one of the most challenging targets in cancer research. #CancerResearch

#AACR25 | <a href="/LauraSoucek/">Laura Soucek</a>, Director of VHIO’s Preclinical and Translational Research Program, has chaired and spoken at the <a href="/AACR/">AACR</a> Annual Meeting on strategies to target MYC, one of the most challenging targets in cancer research.

#CancerResearch